Produktname:2,4-Dichloro-5-fluoropyrimidine
IUPAC Name:2,4-dichloro-5-fluoropyrimidine
- CAS:2927-71-1
- Molekulare Formel:C4HCl2FN2
- Reinheit:95%+
- Katalognummer:CM219871
- Molekulargewicht:166.96
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2927-71-1
- Molekulare Formel:C4HCl2FN2
- Schmelzpunkt:-
- SMILES-Code:FC1=CN=C(Cl)N=C1Cl
- Dichte:
- Katalognummer:CM219871
- Molekulargewicht:166.96
- Siedepunkt:
- Mdl-Nr.:MFCD03412264
- Lagerung:
Category Infos
- Pyrimidines
- Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Column Infos
- Abemaciclib
- Lilly announced the five-year results of a pre-planned analysis of Phase 3 MonarchE study, which evaluated two years of adjuvant Verzenio® (Abemaciclib) in combination with endocrine therapy (ET) compared with ET alone in patients with HR+, HER2-, node-positive early breast cancer (EBC) at a high risk of recurrence. Abemaciclib is the first and only CDK4/6 inhibitor approved for the treatment of node-positive, high-risk early breast cancer (EBC) patients.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.